Stay updated on FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Sign up to get notified when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.

Latest updates to the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page
- Check6 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedAdded a note that publications are automatically filled from PubMed and may not be about the study; updated Revision to v3.3.2. Removed the previous PubMed note stating publications are from PubMed and automatically generated by ClinicalTrials.gov with NCT Number and v3.2.0; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedA general operating-status notice about government funding was removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.3%

- Check42 days agoChange DetectedOnly minor visual/layout adjustments were observed; core study details, eligibility criteria, and study status remain unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check71 days agoChange DetectedUpdates to version to v3.2.0 and addition of a government-operating-status notice; removal of a specific disease name (B-cell chronic lymphocytic leukemia) from the content. The new notice may affect user expectations about data freshness and response times.SummaryDifference4%

- Check78 days agoChange DetectedPage updated to version v3.1.0 and adds information about B-cell lymphoma; previous version tag v3.0.2 is removed.SummaryDifference0.2%

- Check92 days agoChange DetectedPage updated to v3.0.2 from v3.0.1; 'Back to Top' link removed.SummaryDifference0.2%

Stay in the know with updates to FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial
Enter your email address, and we'll notify you when there's something new on the FT596 in Monotherapy and Combo with Anti-CD20 mAbs Clinical Trial page.